Loading...
Loading...
ANGO| Name | Value |
|---|---|
| Revenues | 79.1M |
| Cost of Revenue | 38.8M |
| Gross Profit | 40.3M |
| Operating Expense | 47.0M |
| Operating I/L | -13.1M |
| Other Income/Expense | 0.5M |
| Interest Income | 0.5M |
| Pretax | -12.6M |
| Income Tax Expense | 16.4M |
| Net Income/Loss | -29.0M |
AngioDynamics, Inc. specializes in designing, manufacturing, and selling medical, surgical, and diagnostic devices for peripheral vascular disease treatment, vascular access, oncology, and surgical settings. Its product line includes NanoKnife and solero microwave tissue ablation systems, radiofrequency ablation products, BioSentry tract sealant systems, angiographic catheters, guidewires, percutaneous drainage catheters, and endovascular therapies for thrombus management and venous insufficiency. The company also offers a range of catheters and related accessories for delivering short-term drug therapies. AngioDynamics targets interventional radiologists, cardiologists, vascular surgeons, urologists, oncologists, and critical care nurses through direct sales and distributor relationships.
